New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Arbutus Biopharma Corporation
ABUS
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

749M

Biotechnology

Next Earning date - 06 Nov 2024

749M

Biotechnology

Next Earning date - 06 Nov 2024

3.97USD
Shape-0.08 ( -1.98%)
favorite-chart

Relative Strenght

88
favorite-chart

Volume Buzz

-56%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

16%

Quote Panel

Shape
Updated October 26, 2024
1W -2.46 % 1M 3.66 % 3M 5.03 % 1Y 129.48 %

Key Metrics

Shape
  • Market Cap

    749.47M


  • Shares Outstanding

    188.78M


  • Share in Float

    146.67M


  • Dividende

    0


  • Earning Date

    06 Nov 2024


  • Price Target

    3.97


  • Average Volume

    1.13M


  • Beta

    1.907


  • Range

    1.7-4.72


  • Industry

    Biotechnology


  • Website

    https://www.arbutusbio.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

74.49x

P/S Ratio

6.10x

P/B Ratio

0.1

Debt/Equity

-766.2%

Net Margin

$-0.5

EPS

How ABUS compares to sector?

P/E Ratio

Relative Strength

Shape

ABUS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$6M

Shape262%

2025-Revenue

$0.35

Shape-219%

2025-EPS

$6M

Shape70%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Jefferies

upgrade

Previous: Not converted

2022-02-02

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.12
vs -0.24

Q4.22

arrow
arrow

N/A

-0.14
vs -0.15

Q1.23

arrow
arrow

N/A

-0.10
vs -0.11

Q2.23

arrow
arrow

N/A

-0.10
vs -0.10

Q3.23

arrow
arrow

N/A

-0.12
vs -0.12

Q4.23

arrow
arrow

N/A

-0.12
vs -0.14

Q1.24

arrow
arrow

N/A

-0.10
vs -0.10

Q2.24

arrow
arrow

N/A

-0.11
vs -0.10

Q3.24

arrow
arrow

N/A

-0.09
vs -0.12

Q4.24

arrow
arrow

N/A

-0.09
vs -0.12

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+78%

6M  vs 3.3M

Q4.22

arrow
arrow

+95%

6.2M  vs 3.2M

Q1.23

arrow
arrow

-47%

6.7M  vs 12.6M

Q2.23

arrow
arrow

-67%

4.7M  vs 14.2M

Q3.23

arrow
arrow

-22%

4.7M  vs 6M

Q4.23

arrow
arrow

-66%

2.1M  vs 6.2M

Q1.24

arrow
arrow

-77%

1.5M  vs 6.7M

Q2.24

arrow
arrow

-63%

1.7M  vs 4.7M

Q3.24

arrow
arrow

-60%

1.9M  vs 4.7M

Q4.24

arrow
arrow

-9%

1.9M  vs 2.1M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-12%

-0.12
vs -0.09

Q4.22

arrow
arrow

-17%

-0.17
vs -0.12

Q1.23

arrow
arrow

-11%

-0.11
vs -0.17

Q2.23

arrow
arrow

-13%

-0.13
vs -0.11

Q3.23

arrow
arrow

-17%

-0.17
vs -0.13

Q4.23

arrow
arrow

-18%

-0.18
vs -0.17

Q1.24

arrow
arrow

-16%

-0.16
vs -0.18

Q2.24

arrow
arrow

-16%

-0.16
vs -0.16

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

134

134
vs 119

13%

Q4.22

arrow
arrow

121

121
vs 134

-10%

Q1.23

arrow
arrow

131

131
vs 121

8%

Q2.23

arrow
arrow

118

118
vs 131

-10%

Q3.23

arrow
arrow

106

106
vs 118

-10%

Q4.23

arrow
arrow

122

122
vs 106

15%

Q1.24

arrow
arrow

128

128
vs 122

5%

Q2.24

arrow
arrow

135

135
vs 128

5%

Earnings Growth

Latest News